Aaron Ehlinger

Company: Abbvie

Job title: Principal Research Scientist

Seminars:

From Technology to Application: Exploring Hit ID Approaches to Target E3 Ligase 9:00 am

• Taking a combined approach to designing and executing hit ID strategies on E3 ligase • Diving into upstream workflows to combine ligase biology, target deconvolution, and cellular context • Showcasing how DEL screening provides deeper insights into target biology for hard-to-drug targetsRead more

day: Day One

Panel Discussion: From Diversity to Novelty – Upgrading Library Designs for High-Throughput Screening 1:30 pm

Constructing diverse compound libraries with a focus on novel chemotypes for large-scale screening Perfecting our understanding of DELs to expand chemical diversity and coverage of target classes Determining the most appropriate libraries for a given target to maximize hit opportunityRead more

day: Day One